US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting
Fasenra carries labeled warnings and precautions for hypersensitivity reactions (e.g., anaphylaxis, angioedema, urticaria, rash) and parasitic (helminth) infection. The Prescribing Information (PI) advises patients to not abruptly discontinue systemic or inhaled corticosteroids upon initiation of Fasenra the...